388 related articles for article (PubMed ID: 35383293)
1. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway.
Wang Y; Yan S; Liu X; Deng F; Wang P; Yang L; Hu L; Huang K; He J
Cell Death Differ; 2022 Oct; 29(10):1982-1995. PubMed ID: 35383293
[TBL] [Abstract][Full Text] [Related]
2. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
[TBL] [Abstract][Full Text] [Related]
3. EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2.
Wang B; Jin Y; Liu J; Liu Q; Shen Y; Zuo S; Yu Y
Redox Biol; 2023 Sep; 65():102825. PubMed ID: 37531930
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
5. Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2/glutathione peroxidase 4 signaling pathways.
Lu Z; Liu Z; Fang B
Bioengineered; 2022 Apr; 13(4):9145-9155. PubMed ID: 35363601
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation.
Zhang H; Pan J; Huang S; Chen X; Chang ACY; Wang C; Zhang J; Zhang H
Redox Biol; 2024 Apr; 70():103066. PubMed ID: 38359744
[TBL] [Abstract][Full Text] [Related]
8. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD.
Zhang Z; Fu C; Liu J; Sai X; Qin C; Di T; Yang Y; Wu Y; Bian T
Int J Chron Obstruct Pulmon Dis; 2021; 16():3347-3362. PubMed ID: 34934311
[TBL] [Abstract][Full Text] [Related]
10. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
11. Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling.
Yu Y; Wu T; Lu Y; Zhao W; Zhang J; Chen Q; Ge G; Hua Y; Chen K; Ullah I; Zhang F
Free Radic Biol Med; 2022 Nov; 193(Pt 1):108-121. PubMed ID: 36241072
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
13. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
[TBL] [Abstract][Full Text] [Related]
14. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4.
Huang BW; Ray PD; Iwasaki K; Tsuji Y
FASEB J; 2013 Sep; 27(9):3763-74. PubMed ID: 23699174
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the Cardioprotective Potential of Diacerein in Doxorubicin Cardiotoxicity: Mitigating Ferritinophagy-Mediated Ferroptosis via Upregulating NRF2/SLC7A11/GPX4 Axis.
El-Gohary RM; Okasha AH; Abd El-Azeem AH; Abdel Ghafar MT; Ibrahim S; Hegab II; Farghal EE; Shalaby SAF; Elshora OA; ElMehy AE; Barakat AN; Amer BS; Sobeeh FG; AboEl-Magd GH; Ghalwash AA
Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671940
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
19. Hemin mitigates contrast-induced nephropathy by inhibiting ferroptosis via HO-1/Nrf2/GPX4 pathway.
Gao Z; Zhang Z; Gu D; Li Y; Zhang K; Dong X; Liu L; Zhang J; Chen J; Wu D; Zeng M
Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):858-870. PubMed ID: 35598290
[TBL] [Abstract][Full Text] [Related]
20. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
